These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33275155)

  • 21. Listing practices and graft utilization of hepatitis C-positive deceased donors in liver and kidney transplant.
    Kling CE; Perkins JD; Biggins SW; Johnson CK; Limaye AP; Sibulesky L
    Surgery; 2019 Jul; 166(1):102-108. PubMed ID: 31072671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
    Hannan HA; Goldberg DS
    J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
    Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
    Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
    Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test results.
    Theodoropoulos N; Kroll-Desrosiers A; Ison MG
    Transpl Infect Dis; 2020 Aug; 22(4):e13275. PubMed ID: 32144838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac transplantation from non-viremic hepatitis C donors.
    Patel SR; Madan S; Saeed O; Sims DB; Shin JJ; Nucci C; Borukhov E; Goldstein DY; Jakobleff W; Forest S; Vukelic S; Murthy S; Reinus J; Puius Y; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2018 Oct; 37(10):1254-1260. PubMed ID: 30126825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation.
    Leeaphorn N; Attieh RM; Wadei HM; Mao SA; Mao MA; Pungpapong S; Taner B; Cheungpasitporn W; Jarmi T
    Transplant Proc; 2024; 56(6):1513-1521. PubMed ID: 38997885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
    Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
    Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.
    Haugen CE; Holscher CM; Luo X; Bowring MG; Orandi BJ; Thomas AG; Garonzik-Wang J; Massie AB; Philosophe B; McAdams-DeMarco M; Segev DL
    JAMA Surg; 2019 May; 154(5):441-449. PubMed ID: 30758494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis.
    Northup PG; Argo CK; Nguyen DT; McBride MA; Kumer SC; Schmitt TM; Pruett TL
    Transpl Int; 2010 Oct; 23(10):1038-44. PubMed ID: 20444239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study.
    Crismale JF; Khalid M; Bhansali A; De Boccardo G; Khaim R; Florman SS; Shapiro R; Schiano TD
    Clin Transplant; 2020 Jan; 34(1):e13761. PubMed ID: 31808193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional Variation in Utilization and Outcomes of Liver Allografts From Donors With High Body Mass Index and Graft Macrosteatosis: A Role for Liver Biopsy.
    Steggerda JA; Kim IK; Malinoski D; Klein AS; Bloom MB
    Transplantation; 2019 Jan; 103(1):122-130. PubMed ID: 30048394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing multiorgan heart transplantation with hepatitis C virus donors in the current-era.
    Madan S; Patel SR; Vlismas P; Hemmige V; Saeed O; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2021 Nov; 40(11):1382-1386. PubMed ID: 34176726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation.
    Renz JF; Kin C; Kinkhabwala M; Jan D; Varadarajan R; Goldstein M; Brown R; Emond JC
    Ann Surg; 2005 Oct; 242(4):556-63; discussion 563-5. PubMed ID: 16192816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation.
    Hartwig MG; Patel V; Palmer SM; Cantu E; Appel JZ; Messier RH; Davis RD
    Transplantation; 2005 Aug; 80(3):320-5. PubMed ID: 16082326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Elderly Allografts in Liver Transplantation.
    Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
    Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non-hepatitis C-infected donors: time to revise the kidney donor profile index - a retrospective cohort study.
    Yazawa M; Balaraman V; Tsujita M; Azhar A; Talwar M; Bhalla A; Potukuchi PK; Eason JD; Kovesdy CP; Molnar MZ
    Transpl Int; 2020 Dec; 33(12):1732-1744. PubMed ID: 32935416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.